UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 1, 2016

 

PRA Health Sciences, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-36732

 

46-3640387

(State or Other
Jurisdiction of Incorporation)

 

(Commission File Number)

 

(I.R.S. Employer
Identification No.)

 

4130 ParkLake Avenue

Suite 400

Raleigh, NC 27612

(919) 786-8200

(Address, including zip code, and telephone number,

including area code, of registrant’s principal executive offices)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o                 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o                 Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o                 Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o                 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 5.07.                                        Submission of Matters to a Vote of Security Holders.

 

(a) (b)

 

On June 1, 2016, PRA Health Sciences, Inc. (the “Company”) held its 2016 annual meeting of stockholders.  A quorum was present at the meeting, as required by the Company’s Amended and Restated Bylaws.  The immediately following charts set forth the number of votes cast for and against, and the number of abstentions votes and broker non-votes, with respect to each matter voted upon by the stockholders.

 

Proposal 1 — Election of Directors

 

The following three individuals were elected to the Company’s Board of Directors to serve as Class II directors until the Company’s 2019 annual meeting of stockholders and until their successors have been duly elected and qualified.

 

 

 

Votes
For

 

Votes
Withheld

 

Broker
Non-Votes

 

Jeffrey T. Barber

 

57,373,570

 

249,084

 

556,080

 

Linda S. Grais, M.D.

 

57,201,016

 

421,638

 

556,080

 

Ali J. Satvat

 

44,654,905

 

12,967,749

 

556,080

 

 

Proposal 2 — Ratification of the Appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm for 2016

 

The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016 was ratified.

 

Votes
For

 

Votes
Against

 

Votes
Abstained

 

58,165,377

 

7,733

 

5,624

 

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

PRA Health Sciences, Inc.

 

 

 

 

Date: June 2, 2016

 

 

 

By:

/s/ Linda Baddour

 

Name:

Linda Baddour

 

Title:

Executive Vice President, Chief Financial Officer and Secretary

 

3